Environmental tobacco smoke and Parkinson's disease

Movement Disorders

Volumn 27, Issue 2, 2012, Pages 293-297

  Searles Nielsen, Susan ^a   Gallagher, Lisa G ^a   Lundin, Jessica I ^a   Longstreth, W T ^a   Smith Weller, Terri ^a   Franklin, Gary M ^a   Swanson, Phillip D ^a   Checkoway, Harvey ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Environmental tobacco smoke pollution; Idiopathic Parkinson's disease; Passive smoking; Smoking

Indexed keywords

ACTIVE SMOKING; ADULT; AGED; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; IDIOPATHIC DISEASE; MALE; NOTE; PARKINSON DISEASE; PASSIVE SMOKING; PRIORITY JOURNAL; RISK REDUCTION; SMOKING;

AGED; CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 84856975204     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.24012     Document Type: Note

References (19)

1. Chen H, Huang X, Guo X, et al. Smoking duration, intensity, and risk of Parkinson disease. Neurology. 2010; 74: 878-884.
2. De Palma G, Dick FD, Calzetti S, et al. A case-control study of Parkinson's disease and tobacco use: gene-tobacco interactions. Mov Disord. 2010; 25: 912-919.
3. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol. 2002; 52: 276-284.
4. Ritz B, Ascherio A, Checkoway H, et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol. 2007; 64: 990-997.
5. Thacker EL, O'Reilly EJ, Weisskopf MG, et al. Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology. 2007; 68: 764-768.
6. Quik M, Huang LZ, Parameswaran N, Bordia T, Campos C, Perez XA. Multiple roles for nicotine in Parkinson's disease. Biochem Pharmacol. 2009; 78: 677-685.
7. Castagnoli K, Murugesan T. Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links? Neurotoxicology. 2004; 25: 279-291.
8. Gasser T. Update on the genetics of Parkinson's disease. Mov Disord. 2007; 22( Suppl 17): S343-S350.
9. Bierut LJ. Genetic variation that contributes to nicotine dependence. Pharmacogenomics. 2007; 8: 881-883.
10. Tanner CM, Goldman SM, Aston DA, et al. Smoking and Parkinson's disease in twins. Neurology. 2002; 58: 581-588.
11. Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL. Risk and protective factors for Parkinson's disease: a study in Swedish twins. Ann Neurol. 2005; 57: 27-33.
12. Bharucha NE, Stokes L, Schoenberg BS, et al. A case-control study of twin pairs discordant for Parkinson's disease: a search for environmental risk factors. Neurology. 1986; 36: 284-288.
13. Jaakkola MS, Jaakkola JJ. Assessment of exposure to environmental tobacco smoke. Eur Respir J. 1997; 10: 2384-2397.
14. Mellick GD, Gartner CE, Silburn PA, Battistutta D. Passive smoking and Parkinson disease. Neurology. 2006; 67: 179-180.
15. O'Reilly EJ, Chen H, Gardener H, Gao X, Schwarzschild MA, Ascherio A. Smoking and Parkinson's disease: using parental moking as a proxy to explore causality. Am J Epidemiol. 2009; 169: 678-682.
16. Tanaka K, Miyake Y, Fukushima W, et al. Active and passive smoking and risk of Parkinson's disease. Acta Neurol Scand. 2010; 122: 377-382.
17. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WTJ, Swanson PD. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol. 2002; 155: 732-738.
18. StataCorp. Stata statistics/data analysis special edition, version 11.1. College Station, TX: StataCorp; 2009.
19. Heinrich J, Hölscher B, Seiwert M, Carty CL, Merkel G, Schulz C. Nicotine and cotinine in adults' urine: the German Environmental Survey 1998. J Expo Anal Environ Epidemiol. 2005; 15: 74-80.